ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Psychiatry · J Affect Disord · 2026-02-23

Secondary analysis of a trial in 49 adolescents with MDD given three esketamine or midazolam infusions: 10 inflammatory markers changed over time in both groups, with no significant drug effect; exploratory links of IL-8, IFN-γ and C4 with response.

Secondary analysisn = 49
Lan et al. Multiple peripheral inflammatory markers in adolescents with major depressive disorder treated with repeated esketamine infusions: results from a randomized controlled trial

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.